Paraneoplastic neurological disorders in breast cancer

Breast

Volumn 12, Issue 3, 2003, Pages 203-207

  Gatti, Giovanna ^a,b   Simsek, S ^a   Kurne, A ^c   Zurrida, S ^a,b   Naninato, P ^a   Veronesi, P ^a   Frasson, A ^a,d   Millen, E ^a   Rososchansky, J ^a   Luini, A ^a  

^a Divisione di Senologia Medica   (Italy)

^b Insituto Europeo di Oncologia   (Italy)

^c HACETTEPE UNIVERSITY   (Turkey)

^d PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Breast carcinoma; Neurological disorders; Paraneoplastic syndrome

Indexed keywords

ARTICLE; BREAST CARCINOMA; CANCER PATIENT; CEREBELLUM DEGENERATION; CLINICAL FEATURE; DISEASE ASSOCIATION; HUMAN; MOTOR NEURON DISEASE; MYOCLONUS; OPSOCLONUS; PARANEOPLASTIC NEUROPATHY; PATHOGENESIS; PRIORITY JOURNAL; RETINOPATHY; SENSORIMOTOR NEUROPATHY; STIFF MAN SYNDROME;

EID: 12444328665     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9776(03)00011-0     Document Type: Article

References (19)

1. Dalmau J, Gultekin H S, Posner J B. Paraneoplastic neurologic syndromes: pathogenesis and physiopathology. Brain Pathol 1999; 9: 275-284.
2. Giometto B, Taraloto B, Graus F. Autoimmunity in paraneoplastic neurological syndromes. Brain Pathol 1999; 9: 261-273.
3. Posner J B. Paraneoplastic syndromes. In: Posner J B eds. Neurological Complication of Cancer. Contemporary Neurology Series 45. New York: OUP 1995; 353-383.
4. Verschuuren J J, Dalmau J, Horard R, Posner J B. Paraneoplastic anti-Hu serum: studies on human tumor cell lines. J Neuroimmunol 1997; 79: 202-205.
5. Voltz R. Paraneoplastic neurological syndromes: an up date on diagnosis, pathogenesis, therapy. Lancet 2002; 1: 294-305.
6. Dropcho E J. Autoimmune central nervous system paraneoplastic disorders: mechanisms, diagnosis, and therapeutic options. Ann Neurol 1995; 1: 102-112.
7. Cunningham J, Graus F, Anderson N, Posner J B. Partial characterization of the Purkinje cell antigens in paraneoplastic cerebellar degeneration. Neurology 1986; 36: 1163-1168.
8. Pranzatelli M R. Paraneoplastic syndromes: an unsolved murder. Semin Pediatr Neurol 2000; 7: 118-130.
9. Voltz R, Dalmau J O, Posner J B, Rosenfeld M R. T-cell receptor analysis in anti-Hu associated paraneoplastic encephalomyelitis. Neurology 1998; 51: 1146-1150.
10. Dalmau J O, Posner J B. Neurological paraneoplastic syndromes. Neuroscientist 1998; 4: 443-453.
11. Wilkinson P C, Zeromski J. Immunofluorescent detection of antibodies against neurons in sensory carcinomatous neuropathy. Brain 1959; 88: 529-538.
12. Darnell R B. The importance of defining the paraneoplastic neurologic disorders. N Engl J Med 1999; 23: 1831-1833.
13. Peterson K, Rosenblum M K, Kotanides H, Posner J B. Paraneoplastic cerebellar degeneration I. A. clinical analysis of 55 anti-Yo antibody-positive patients. Neurology 1992; 42: 1931-1937.
14. Folli F, Solimena M, Cofiell R et al. Autoantibodies to a 128-kd synaptic protein in three women with the stiff-man syndrome and breast cancer. N Engl J Med 1993; 25: 546-551.
15. Folli F, Piccolo G. Stiff-man syndrome: pathogenetic, nosological, and therapeutic considerations. In: Vincent A, Martino G eds. Antibodies in Neurological Diseases, Chapter 9, 1st edition. Milano: Springer-Verlag Italia, 2002; 124-135.
16. Teruaki I, Inoue A, Koh C S et al. A study on a new antineural antibody in a case of paraneoplastic sensory neuropathy associated with breast carcinoma. J Neurol Psychiatry 1997; 63: 516-519.
17. Dalmau J O, Posner J B. Paraneoplastic syndromes. Arch Neurol 1999; 56: 405-408.
18. Graus F, Dalmau J O, Rene R et al. Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival. J Clin Oncol 1997; 15: 2866-2872.
19. Dalmau J O, Furneaux H M, Rosenblum M K et al. Detection of the anti-Hu antibody in specific regions of the nervous system and tumor from patients with paraneoplastic encephalomyelitis/sensory neuronopathy. Neurology 1991; 41: 1757-1764.